Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.87
Delayed Data
As of Jul 31
 0.00 / 0.00%
Today’s Change
6.72
Today|||52-Week Range
9.24
+4.93%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +39.77% increase from the last price of 7.87.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$2.1M
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.15%
 
 
 
 
 
 
Growthannually 4.50%
 
 
 
 

Sales

Growthquarterly 36.31%
 
 
 
 
 
 
Growthannually 613.75%
 
 
 
Key to the earnings and sales forecast charts.